PATENT CLAIM ANALYSIS

Application Number: 16037368
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "249000"]

Abstract:
The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as TLR7/8 antagonists.

Claim (Index 7):
The compound of  claim 1 , wherein each R 4  is independently C 1-6  aliphatic, \u2014OR, \u2014C(O)R, \u2014CO 2 R, \u2014C(O)N(R) 2 , \u2014NRC(O)R, \u2014NRC(O)OR, \u2014NRC(O)N(R) 2 , \u2014NRSO 2 R, or \u2014N(R) 2 ; each of which is optionally substituted.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 95.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15381406', '15620049', '15016569', '15680683', '15267606']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7955636730112148
- 35 USC 102 Novelty (BERT): 0.5562397689415536
- Combined Prediction Score: 0.7716312826042486
- Mean Citation Score: 329.576652
- Max Citation Score: 412.4425
- Similarity Product: 407.9056417433917

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test